Overview

Clinical Study of Lipoic Acid on Ischemic Heart Failure

Status:
Not yet recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy of alpha-lipoic acid(α-LA) on mortality in patients with ischemic heart failure (NYHA Class II - IV and EF =< 45%).
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Thioctic Acid